Rapid Dose Therapeutics Corp. DOSE

Company Overview

Rapid Dose Therapeutics Corp. is a Canadian life sciences company operating in the pharmaceutical drug delivery and healthcare technology industries. The company focuses on the development, manufacture, and commercialization of oral thin film drug delivery technologies, designed to deliver active pharmaceutical ingredients and nutraceuticals without the need for water or swallowing pills. Its core value proposition centers on improving patient compliance, speed of onset, and dosing accuracy.

The company’s primary business is built around its proprietary QuickStrip™ Oral Thin Film Platform, which is used for both pharmaceutical and nutraceutical applications. Rapid Dose Therapeutics serves pharmaceutical companies, nutraceutical brands, and contract development and manufacturing (CDMO) customers, with an emphasis on pain management, supplements, and potential cannabinoid-based formulations. Founded in Canada, the company evolved from an R&D-focused drug delivery innovator into a commercial-stage manufacturer with regulatory-compliant production capabilities.